Skip to main content
PM logo

PM · Philip Morris International Inc.

Track PM — free
$192.73 -1.65 (-0.85%) At close · Nov 18
Market Cap
$300.40B
Shares
1.56B
Volume · Nov 18 6.29M Avg daily vol (3M) 4.62M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$192.73 Open$192.51 Day$191.07–194.04 52W close$147.81–211.28 Avg vol 30d5.0M Short int14.9M · 1.0% of shares · 3.2d Short vol33% Last earningsOct 21, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 23

Up next

Feb 5, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Oct 23
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

PMI’s net revenues were $32.8 billion for the nine months ended September 30, 2026, up 8.2%, and $11.4 billion for the three months ended September 30, 2026, up 5.5%. Diluted EPS was $5.48 and $2.12, respectively.

Revenue $11.44B ▲ 5.5% Net income $3.31B ▼ 4.7% Diluted EPS $2.12 ▼ 4.9%
Read from the MD&A section
Oct 21
Earnings call
Q3 2026 earnings call

Philip Morris International reported Q3 organic net revenue growth of plus 7.1% to $11.4 billion, adjusted diluted EPS of $2.36, and ICOS adjusted IMS growth of plus 7.1%. Full-year organic net revenue growth is forecast at plus 5% to plus 7%.

Read from the first part of this long document
Oct 21
Current report 8-K
Financial results

Philip Morris International reported Q3 operating income up 14.1% and adjusted diluted EPS of $2.36, up 5.4%; it forecast 2026 adjusted diluted EPS growth of 9.9% to 11.9% and raised the dividend 8.8% to $1.60 per share.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$43.14B
Trailing 12 months
Net income (TTM)
$10.71B
Trailing 12 months
Revenue growth YoY
+5.5%
Year over year
Operating margin
38.6%
Trailing 12 months
P / E (TTM)
28.2
Trailing earnings · reciprocal yield 3.5%
FCF yield
4.5%
TTM · current market cap
Return on invested capital
40.0%
Trailing 12 months
Net cash
−$40.88B
Latest balance sheet
Dividend yield
3.1%
Trailing 12 months
Shares change YoY
+0.1%
Year over year · more shares
Price change (1Y)
+23.7%
Trailing year
Short interest
1.0%
Latest settlement · 3.2 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Oct 21, 2026
Q3 FY26

TL;DR. PMI delivered record Q3 revenue and operating income, with strong IQOS, ZYN, VEEV and combustible performance, and forecasts 5% to 7% full-year organic revenue growth. Risks include guidance leaning toward the lower half of its ranges, near-zero expected U.S. Q4 profitability, geopolitical cost pressure, declining cigarette volumes and a 41.1% decline in year-to-date U.S. adjusted OCI.

Bullish
  • + Q3 net revenues rose 7.1% organically to $11.4 billion and operating income rose 10.5% organically, setting records for quarterly net revenue, gross profit and operating income.
  • + IQOS HTU adjusted IMS grew 7.1%, or 10% excluding Japan and Poland, and shipments reached the high end of prior expectations.
  • + VEEV quarterly shipments increased 61.6%, extending the brand's European leadership and producing promising results in newer markets.
  • + U.S. ZYN shipments grew 4.2% to 3.2 billion pouches, while segment net revenues rose 22.7% and gross profit rose 24.2%.
  • + International combustibles delivered 7.8% organic revenue growth and 9.8% organic gross-profit growth, while Marlboro reached a record 11.4% category share.
  • + Full-year organic net revenue growth is forecast at 5% to 7%, with greater likelihood of landing in the middle or upper half of the range.
Bearish
  • − Management now expects full-year operating-income and EPS growth to land in the midpoint or lower half of their respective guidance ranges.
  • − Q4 U.S. adjusted OCI is expected around zero or slightly negative as elevated investment and the 20-pouch transition reduce revenue per pouch by approximately 25%.
  • − Geopolitical conflicts are expected to reduce full-year adjusted diluted EPS growth by approximately one percentage point.
  • − Reported Q3 diluted EPS declined 4.9% to $2.12, primarily because of the fair-value adjustment for equity-security investments.
  • − Cigarette volumes declined 1.2% year to date, and full-year cigarette volume is now expected to decline by a similar level.
  • − U.S. adjusted OCI declined 41.1% organically to $550 million for the first nine months.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +5%
above
Price vs 50-day avg −2%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 71%
mid-range
Momentum
relative strength
Strong
1-month return −2%
trailing
6-month return +9%
trailing
YTD return +20%
this year
Relative strength +12%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $197 › 200d $183 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +188 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.95% of shares out · ▼ -14.0% MoM · 3.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
3,006 holders — near 3-yr high, broad support
Squeeze score 53
elevated · 0–100
Fundamentals
Strong
Revenue growth +7%
Y/Y
Gross margin 67%
expanding
EPS growth +61%
Y/Y
Free cash flow $10.7B
Valuation P/E 28.2
rich
Buyback $7.0B
authorized
Balance sheet $44.0B
net debt
Quant / Vol
risk profile
Moderate
Volatility 28%
annualized · 1-yr
Max drawdown −19%
past year
ATR 2.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 3
Latest guidance · from the 8-K filed Oct 21, 2026
2026 Full-Year Forecast
Reported Diluted EPS Lowered $7.11 – $7.26
Apr 22, 2026 $7.56 – $7.71 changed to Oct 21, 2026 $7.11 – $7.26
prior FY $7.26 midpoint −1.0% Y/Y
2026 Full-Year Forecast Assumptions
Organic operating income growth Non-GAAP Maintained 7% – 9%
Jul 22, 2026 7% – 9% changed to Oct 21, 2026 7% – 9%
Full-year amortization of acquired intangibles $0.50
Operating cash flow Maintained $13.5B
Jul 22, 2026 $13.5B changed to Oct 21, 2026 $13.5B
Capital expenditures Maintained $1.4B – $1.6B
Jul 22, 2026 $1.4B – $1.6B changed to Oct 21, 2026 $1.4B – $1.6B
Previous outlook earlier release · from the Earnings Call filed Jul 22, 2026

Still-open targets the latest release did not restate under the same label.

Organic net revenue growth · 2026 5% – 7%
Adjusted diluted EPS · 2026 $8.26 – $8.41
Prior guidance period ended · from the Earnings Call filed Jul 22, 2026
Adjusted diluted EPS · Q3 $2.20 – $2.25
Guided vs delivered · last 3 settled
Reported diluted EPS 2025 Full-Year
guided $7.39 – $7.49
$7.26 Miss −2.4%
Reported Diluted EPS 2023 Full-Year
guided $4.95 – $4.98
$5.02 Beat +1.1%
Reported Diluted EPS First-Quarter 2023
guided $1.28 – $1.33
$1.28 In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+5% Bullish
Price vs 50-day avg
−2% Neutral
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
71% Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $197 › 200d $183 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +188 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.95% of shares out · ▼ -14.0% MoM · 3.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
3,006 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $148 Now $193 · 71% Range high $211
vs 200-day avg +5% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted IMS growth outside Europe and Japan 12.7% third quarter filing —
annualized dividend rate 6.4 the third quarter of 2026 filing —
AveragePrice PaidPer Share $182.79 For the Quarter Ended September 30, 2026 filing —
Depreciation and amortization expense: International Combustibles 67M the three months ended September 30, 2026 filing —
Depreciation and amortization expense: International Smoke-Free 93M the three months ended September 30, 2026 filing —
Depreciation and amortization expense: Other 324M the three months ended September 30, 2026 filing —
Depreciation and amortization expense: U.S. 27M the three months ended September 30, 2026 filing —
Dutch pension plan buy-out loss $74M the third quarter of 2026 filing —
HTU adjusted IMS growth 7.1% third quarter filing —
increase in the quarterly dividend 8.8% the third quarter of 2026 filing —
IQOS category share 68% third quarter filing —
IQOS HTU adjusted IMS growth in Europe 6% third quarter filing —
IQOS HTU adjusted market share 11.6% third quarter filing —
IQOS shipment volume 41.5B third quarter filing —
Total depreciation and amortization expense 511M the three months ended September 30, 2026 filing —
Total depreciation and amortization expense by segment 187M the three months ended September 30, 2026 filing —
Total Number of Shares Repurchased 10,304 For the Quarter Ended September 30, 2026 filing —
total pre-tax restructuring charges 4M three months ended September 30, 2026 filing —
U.S. smoke-free product shipment volume growth 2.3% third quarter filing —
ZYN shipment growth 4.2% third quarter filing —
cigarette shipment volume in the International Combustibles segment 156.9B the second quarter filing —
Estimated industry volume growth (excluding China and the U.S.) for cigarettes and HTUs 0.8% the three months ended June 30, 2026 filing —
HTU adjusted IMS volume growth 5.1% the three months ended June 30, 2026 filing —
Modern oral volume 0.6B the three months ended June 30, 2026 filing —
Oral SFP shipment volume 5.1B the three months ended June 30, 2026 filing —
restructuring charges $6M For the Three Months Ended June 30, 2026 filing —
Smoke-Free Products shipment volume 48.2B the three months ended June 30, 2026 filing —
Total shipment volume 205.2B the three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Tobacco — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PM
Philip Morris International Inc.
this stock
$300.40B +20.2% +7.3% 28.2 1.0%
MO
Altria Group, Inc.
$126.85B +32.3% -3.1% 15.7 2.4%
BTI
British American Tobacco p.l.c.
$125.62B +3.3% — — 0.3%
RLX
RLX Technology Inc.
$1.78B -37.3% +50.3% — 0.7%
AIIR
AIR Global PLC
$1.14B -40.8% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
3,006
% held
83.2%
Net QoQ
-5.6M sh
Top holder
Capital World Investors
Held Float
View
Held by Funds
Fund positions
1,343
View
Short & Settlement
Short Interest Falling
Shares short
14.9M
Days to cover
3.2d
Change
-2.4M sh
View
Short Volume
Short vol %
33%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
2.3K
Value
$482.9K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
44.1%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 27, 2026
View
Financials
Financials
Revenue (FY)
$40.6B
Net income (FY)
$11.3B
EPS diluted
$7.26
View
Buybacks
Authorized
$7.0B
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 23, 2026
This year
33

PMI’s net revenues were $32.8 billion for the nine months ended September 30, 2026, up 8.2%, and $11.4 billion for the three months ended September 30, 2026, up 5.5%. Diluted EPS was $5.48 and $2.12, respectively.

View
Proposed Sales
Value
$2.6M
Shares
14.4K
Filed
Feb 20, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 21, 2026
View
Investor Relations
Latest news
Philip Morris International Repor…
Published
Oct 21, 2026
View

Performance

5D 20D 120D MTD YTD
PM -1.8% -2.4% +8.7% -7.7% +20.2%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY +2.1% +3.2% +12.1% -4.3% +13.1%

Capital returns

Latest dividend
$1.60 / share · ex Oct 2, 2026
Raised 8.8%
Paid (TTM)
$6.01 / share · 4 payouts
Dividend yield (TTM, derived)
3.12%
Full dividend history
Buyback program · as of Jun 11, 2021
Authorized
$7.00B
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1413329 CUSIP 718172109 13F (30d) 2566 filings 2415 filers Visit website Investor relations